Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) Enterprise Value (2016 - 2026)

Healthequity has reported Enterprise Value over the past 14 years, most recently at -$318.9 million for Q1 2026.

  • Quarterly results put Enterprise Value at -$318.9 million for Q1 2026, down 7.76% from a year ago — trailing twelve months through Jan 2026 was -$318.9 million (down 7.76% YoY), and the annual figure for FY2026 was -$318.9 million, down 7.76%.
  • Enterprise Value for Q1 2026 was -$318.9 million at Healthequity, down from -$309.3 million in the prior quarter.
  • Over the last five years, Enterprise Value for HQY hit a ceiling of -$161.2 million in Q2 2022 and a floor of -$404.0 million in Q1 2024.
  • Median Enterprise Value over the past 5 years was -$290.3 million (2023), compared with a mean of -$276.4 million.
  • Biggest five-year swings in Enterprise Value: surged 78.11% in 2022 and later tumbled 64.14% in 2023.
  • Healthequity's Enterprise Value stood at -$210.2 million in 2022, then crashed by 58.93% to -$334.1 million in 2023, then increased by 3.56% to -$322.2 million in 2024, then increased by 4.01% to -$309.3 million in 2025, then decreased by 3.13% to -$318.9 million in 2026.
  • The last three reported values for Enterprise Value were -$318.9 million (Q1 2026), -$309.3 million (Q4 2025), and -$304.5 million (Q3 2025) per Business Quant data.